REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,449 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page
25
Current page
8
CORRESP

CORRESP filing

Filing date
20 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2024
Reporting date
17 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2024
Reporting date
16 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2024
Reporting date
13 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 000-19034

UPLOAD filing

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 May 2024
Reporting date
03 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 May 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 May 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-19034

ARS

Filing date
25 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19034

REGENERON PHARMACEUTICALS, INC. - DEFA14A

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19034

REGENERON PHARMACEUTICALS, INC. - DEF 14A

Filing date
25 Apr 2024
Reporting date
14 Jun 2024
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
14 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .